The Scientist

» health care, microbiology, immunology and evolution

Most Recent

The former chief of Eli Lilly USA is picked to replace Tom Price, who stepped down in September amid a controversy over the abuse of taxpayer-funded travel.

0 Comments

A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 

1 Comment

image: Equivocal Findings of Alzheimer’s Trial Using Young Blood

Equivocal Findings of Alzheimer’s Trial Using Young Blood

By | November 6, 2017

A team of Stanford University researchers say that administering young people’s blood plasma to Alzheimer’s patients could improve cognitive function, but the results have been criticized.

0 Comments

image: Ecologists Welcome Seventh Great Ape Species into Our Family

Ecologists Welcome Seventh Great Ape Species into Our Family

By | November 2, 2017

The Tapanuli orangutan has been identified as the newest species of great ape, but also likely the most endangered. 

0 Comments

image: These Flies Hijack Frogs’ Love Calls

These Flies Hijack Frogs’ Love Calls

By | November 1, 2017

The phenomenon is one of the few examples of eavesdropping across the vertebrate/invertebrate barrier.

0 Comments

image: These Flies Suck. . . Frogs

These Flies Suck. . . Frogs

By | November 1, 2017

Insects feast on amorous tungara frogs by eavesdropping on their amphibian love songs.

0 Comments

image: Tracking Invasive Fire Ants in Asia

Tracking Invasive Fire Ants in Asia

By | November 1, 2017

These insect transplants have the potential to wreak economic havoc by outcompeting native insects and destroying crops.

0 Comments

image: The Weird Growth Strategy of Earth’s First Trees

The Weird Growth Strategy of Earth’s First Trees

By | October 24, 2017

Ancient fossils reveal how woodless trees got so big: by continuously ripping apart their xylem and knitting it back together.

1 Comment

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

A new study identifies microorganisms residing in the human fallopian tubes and uterus, but some researchers are skeptical of the findings. 

0 Comments

Popular Now

  1. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  2. Man Receives First In Vivo Gene-Editing Therapy
  3. Researchers Build a Cancer Immunotherapy Without Immune Cells
  4. Child Receives Transgenic Skin Over Most of His Body
RayBiotech